Format
Sort by
Items per page

Send to

Choose Destination

Best matches for PRASTERONE/PD:

Prasterone. Kocis P et al. Am J Health Syst Pharm. (2006)

Prasterone (Intrarosa) for dyspareunia. et al. Med Lett Drugs Ther. (2017)

Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders. Triantafyllidou O et al. Hum Fertil (Camb). (2017)

Search results

Items: 1 to 20 of 2583

1.

Neurosteroid dehydroepiandrosterone sulphate enhances pain transmission in rat spinal cord dorsal horn.

Yamamoto G, Kamiya Y, Sasaki M, Ikoma M, Baba H, Kohno T.

Br J Anaesth. 2019 Aug;123(2):e215-e225. doi: 10.1016/j.bja.2019.03.026. Epub 2019 Apr 26.

2.

Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial.

Wang W, Liu H, Li J, Wei D, Zhang J, Wang J, Ma J, Shi Y, Chen ZJ.

Trials. 2019 Jan 15;20(1):50. doi: 10.1186/s13063-018-3146-x.

3.

D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathy.

Stochelski MA, Wilmanski T, Walters M, Burgess JR.

Redox Biol. 2019 Feb;21:101078. doi: 10.1016/j.redox.2018.101078. Epub 2018 Dec 16.

4.

The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.

Seow KM, Ting CH, Huang SW, Ho LT, Juan CC.

Taiwan J Obstet Gynecol. 2018 Oct;57(5):696-704. doi: 10.1016/j.tjog.2018.08.015.

5.

MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.

Zhou DN, Li SJ, Ding JL, Yin TL, Yang J, Ye H.

Curr Med Sci. 2018 Oct;38(5):853-860. doi: 10.1007/s11596-018-1953-7. Epub 2018 Oct 20.

PMID:
30341520
6.

Metabolic and isotopic signature of short-term DHEA administration in women: Comparison with findings in men.

Buisson C, Frelat C, Privat K, Martinat N, Audran M, Collomp K.

Drug Test Anal. 2018 Nov;10(11-12):1744-1754. doi: 10.1002/dta.2519. Epub 2018 Nov 4.

PMID:
30315670
7.

Short-term DHEA administration in recreational athletes: impact on food intake, segmental body composition and adipokines.

Gravisse N, Vibarel-Rebot N, Buisson C, Le Tiec C, Castanier C, Do MC, Gagey O, Audran M, Collomp K.

J Sports Med Phys Fitness. 2019 May;59(5):808-816. doi: 10.23736/S0022-4707.18.08845-X. Epub 2018 Sep 27.

PMID:
30264977
8.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) for symptomatic women in the peri- or postmenopausal phase.

Sauer U, Talaulikar V, Davies MC.

Maturitas. 2018 Oct;116:79-82. doi: 10.1016/j.maturitas.2018.07.016. Epub 2018 Jul 31. Review.

PMID:
30244783
9.

The secretory phenotype of senescent astrocytes isolated from Wistar newborn rats changes with anti-inflammatory drugs, but does not have a short-term effect on neuronal mitochondrial potential.

Maciel-Barón LÁ, Morales-Rosales SL, Silva-Palacios A, Rodríguez-Barrera RH, García-Álvarez JA, Luna-López A, Pérez VI, Torres C, Königsberg M.

Biogerontology. 2018 Oct;19(5):415-433. doi: 10.1007/s10522-018-9767-3. Epub 2018 Aug 10.

PMID:
30097900
10.

DHEA Treatment Effects on Redox Environment in Skeletal Muscle of Young and Aged Healthy Rats.

Jacob MHVM, Fernandes RO, Bonetto JHP, Mendes RH, da R Araujo AS, Belló-Klein A, Ribeiro MFM.

Curr Aging Sci. 2018;11(2):126-132. doi: 10.2174/1874609811666180803125723.

11.

Preface.

Litwack G.

Vitam Horm. 2018;108:xvii-xviii. doi: 10.1016/S0083-6729(18)30062-1. No abstract available.

PMID:
30029739
12.

Dehydroepiandrosterone and Dehydroepiandrosterone-Sulfate and Emotional Processing.

do Vale S, Escera C.

Vitam Horm. 2018;108:413-441. doi: 10.1016/bs.vh.2018.01.022. Epub 2018 Mar 9.

PMID:
30029737
13.

Dehydroepiandrosterone and Experimental Osteoarthritis.

Huang K, Wu LD, Bao JP.

Vitam Horm. 2018;108:367-384. doi: 10.1016/bs.vh.2018.01.021. Epub 2018 Feb 19.

PMID:
30029735
14.

Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.

Aoki K, Terauchi Y.

Vitam Horm. 2018;108:355-365. doi: 10.1016/bs.vh.2018.01.008. Epub 2018 Mar 2. Review.

PMID:
30029734
15.

Dehydroepiandrosterone and Cardiovascular Disease.

Mannella P, Simoncini T, Caretto M, Genazzani AR.

Vitam Horm. 2018;108:333-353. doi: 10.1016/bs.vh.2018.05.001. Epub 2018 Jul 13.

PMID:
30029733
16.

Dehydroepiandrosterone (DHEA)-SO4 Depot and Castration-Resistant Prostate Cancer.

Penning TM.

Vitam Horm. 2018;108:309-331. doi: 10.1016/bs.vh.2018.01.007. Epub 2018 Feb 24. Review.

17.

Mechanisms of Action of Dehydroepiandrosterone.

Clark BJ, Prough RA, Klinge CM.

Vitam Horm. 2018;108:29-73. doi: 10.1016/bs.vh.2018.02.003. Epub 2018 Mar 22.

PMID:
30029731
18.

Dehydroepiandrosterone Research: Past, Current, and Future.

Klinge CM, Clark BJ, Prough RA.

Vitam Horm. 2018;108:1-28. doi: 10.1016/bs.vh.2018.02.002. Epub 2018 Mar 16. Review.

PMID:
30029723
19.

Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma.

Yang WB, Chuang JY, Ko CY, Chang WC, Hsu TI.

Mol Neurobiol. 2019 Apr;56(4):2301-2313. doi: 10.1007/s12035-018-1221-7. Epub 2018 Jul 18.

PMID:
30022431
20.

Female rats are more susceptible to metabolic effects of dehydroepiandrosterone treatment.

Hoefel AL, Arbo BD, Vieira-Marques C, Cecconello AL, Cozer AG, Ribeiro MFM, Kucharski LC.

Can J Physiol Pharmacol. 2018 Nov;96(11):1069-1075. doi: 10.1139/cjpp-2018-0159. Epub 2018 Jul 16.

PMID:
30011383

Supplemental Content

Loading ...
Support Center